MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11.
Mol Med Rep
; 17(3): 3972-3978, 2018 03.
Article
em En
| MEDLINE
| ID: mdl-29286137
ABSTRACT
Liver cancer is the sixth most common malignant tumour and ranks in the top three cancers with regard to mortality due to metastasis and postsurgical recurrence. It is significant to understand the mechanisms underlying liver cancer for diagnosis and treatment. Cumulative evidence suggests that the abnormal regulation of microRNAs (miRNAs/miRs) may contribute to the development and metastasis of cancer. miR124a acts as a tumour suppressor in osteosarcoma, endometrial carcinoma, prostate cancer, and glioblastoma. However, the effects of miR124a in liver cancer and its biological mechanism are not fully understood. It has been demonstrated that miR124a is downregulated and interleukin (IL)11 is upregulated in the liver cancer tissues. In the present study, miR124a upregulation inhibited cell proliferation, migration and promoted cell apoptosis. Through a dualluciferase reporter assay, it was verified that IL11 is a direct target of miR124a. Furthermore, the overexpression of miR124a repressed the secretion of IL11 from hepatoma cells. Finally, it was identified that mimics of miR124a increased the expression of tissue inhibitor of matrix metalloproteinase2 (TIMP2) and Caspase3 and decreased the expression levels of matrix metalloproteinase 2 (MMP2), MMP9, Bcell lymphoma 2, signal transducer and activator of transcription 3 (STAT3), and phosphorylatedSTAT3. In conclusion, the results indicated that miR124a has an important role as a tumour suppressor gene by targeting IL11. These findings may provide novel insights for clinical treatments to prevent the development of liver cancer.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
/
Tipos_de_cancer
/
Outros_tipos
Base de dados:
MEDLINE
Assunto principal:
Regulação Neoplásica da Expressão Gênica
/
Movimento Celular
/
Interleucina-11
/
MicroRNAs
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Mol Med Rep
Ano de publicação:
2018
Tipo de documento:
Article